143 related articles for article (PubMed ID: 27573048)
1. Current treatments for advanced melanoma and introduction of a promising novel gene therapy for melanoma (Review).
Heo JR; Kim NH; Cho J; Choi KC
Oncol Rep; 2016 Oct; 36(4):1779-86. PubMed ID: 27573048
[TBL] [Abstract][Full Text] [Related]
2. Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin.
Brown AB; Yang W; Schmidt NO; Carroll R; Leishear KK; Rainov NG; Black PM; Breakefield XO; Aboody KS
Hum Gene Ther; 2003 Dec; 14(18):1777-85. PubMed ID: 14670128
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Advances and Treatment Options in Metastatic Melanoma.
Johnson DB; Sosman JA
JAMA Oncol; 2015 Jun; 1(3):380-6. PubMed ID: 26181188
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous melanoma.
Eggermont AM; Spatz A; Robert C
Lancet; 2014 Mar; 383(9919):816-27. PubMed ID: 24054424
[TBL] [Abstract][Full Text] [Related]
5. The safety of talimogene laherparepvec for the treatment of advanced melanoma.
Gangi A; Zager JS
Expert Opin Drug Saf; 2017 Feb; 16(2):265-269. PubMed ID: 27989216
[TBL] [Abstract][Full Text] [Related]
6. New therapeutic options for advanced non-resectable malignant melanoma.
Stadler S; Weina K; Gebhardt C; Utikal J
Adv Med Sci; 2015 Mar; 60(1):83-8. PubMed ID: 25596540
[TBL] [Abstract][Full Text] [Related]
7. Surgical treatment options for stage IV melanoma.
Wei IH; Healy MA; Wong SL
Surg Clin North Am; 2014 Oct; 94(5):1075-89, ix. PubMed ID: 25245969
[TBL] [Abstract][Full Text] [Related]
8. Molecular cytogenetics of cutaneous melanocytic lesions - diagnostic, prognostic and therapeutic aspects.
Blokx WA; van Dijk MC; Ruiter DJ
Histopathology; 2010 Jan; 56(1):121-32. PubMed ID: 20055910
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effects of co-administration of suicide gene expressing mesenchymal stem cells and prodrug-encapsulated liposome on aggressive lung melanoma metastases in mice.
Zhang TY; Huang B; Wu HB; Wu JH; Li LM; Li YX; Hu YL; Han M; Shen YQ; Tabata Y; Gao JQ
J Control Release; 2015 Jul; 209():260-71. PubMed ID: 25966361
[TBL] [Abstract][Full Text] [Related]
10. Current Status of Biological Therapies for the Treatment of Metastatic Melanoma.
Tang T; Eldabaje R; Yang L
Anticancer Res; 2016 Jul; 36(7):3229-41. PubMed ID: 27354579
[TBL] [Abstract][Full Text] [Related]
11. Survival of patients with advanced metastatic melanoma: The impact of novel therapies.
Ugurel S; Röhmel J; Ascierto PA; Flaherty KT; Grob JJ; Hauschild A; Larkin J; Long GV; Lorigan P; McArthur GA; Ribas A; Robert C; Schadendorf D; Garbe C
Eur J Cancer; 2016 Jan; 53():125-34. PubMed ID: 26707829
[TBL] [Abstract][Full Text] [Related]
12. [New melanoma immunotherapies: mechanisms of action, efficiency and management of toxicities].
Moura B; Homicsko K; Berthod G; Cerottini JP; Guggisberg D; Gaide O; Maillard MH; Michielin O
Rev Med Suisse; 2015 May; 11(475):1108, 1110-4. PubMed ID: 26152085
[TBL] [Abstract][Full Text] [Related]
13. siRNA preparations in gene therapy of melanoma.
Bogusławska J; Małecki M
Med Wieku Rozwoj; 2013; 17(3):196-201. PubMed ID: 24296443
[TBL] [Abstract][Full Text] [Related]
14. IL-12 gene therapy using an electrically mediated nonviral approach reduces metastatic growth of melanoma.
Lucas ML; Heller R
DNA Cell Biol; 2003 Dec; 22(12):755-63. PubMed ID: 14683586
[TBL] [Abstract][Full Text] [Related]
15. Novel immunotherapies as potential therapeutic partners for traditional or targeted agents: cytotoxic T-lymphocyte antigen-4 blockade in advanced melanoma.
Agarwala SS
Melanoma Res; 2010 Feb; 20(1):1-10. PubMed ID: 19952852
[TBL] [Abstract][Full Text] [Related]
16. Melanoma: the intersection of molecular targeted therapy and immune checkpoint inhibition.
Lau PK; Ascierto PA; McArthur G
Curr Opin Immunol; 2016 Apr; 39():30-8. PubMed ID: 26765776
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy strategies using engineered stem cells for treating gynecologic and breast cancer patients (Review).
Kim YS; Hwang KA; Go RE; Kim CW; Choi KC
Oncol Rep; 2015 May; 33(5):2107-12. PubMed ID: 25760693
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy for metastatic malignant melanoma: evaluation of tolerance to intratumoral injection of cells producing recombinant retroviruses carrying the herpes simplex virus type 1 thymidine kinase gene, to be followed by ganciclovir administration.
Klatzmann D
Hum Gene Ther; 1996 Jan; 7(2):255-67. PubMed ID: 8788175
[TBL] [Abstract][Full Text] [Related]
19. Scientific aspects of gene therapy in melanoma.
Rankin EM
Curr Opin Oncol; 1995 Mar; 7(2):192-6. PubMed ID: 7756385
[TBL] [Abstract][Full Text] [Related]
20. Targeted nanoparticles deliver siRNA to melanoma.
Chen Y; Bathula SR; Yang Q; Huang L
J Invest Dermatol; 2010 Dec; 130(12):2790-8. PubMed ID: 20686495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
